|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|||
|
Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport |
Nuevas Terapias Dirigidas a Modificar el Metabolismo de las Lipoproteínas de Alta Densidad y el Transporte Inverso de Colesterol |
||
|
transporte inverso de colesterol, apolipoproteína A-I, Metabolismo de lipoproteínas de alta densidad |
High-density lipoprotein metabolism, reverse cholesterol transport, apolipoprotein A-I |
||
|
Duffy D, Rader DJ |
DJ Rader, University of Pennsylvania School of Medicine PA 19104 Filadelfia EE.UU. |
||
|
T32 award from the National Heart, Lung and Blood Institute. Dr Rader is supported by grants from the National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases. |
Dr. Rader received grants/research/support and/or honoraria from Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Bruin Pharma, Glaxo-SmithKline and others. |
||
|
Institute for Translational Medicine and Therapeutics, Cardiovascular Institute, and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|